Novan, Inc. (NOVN) financial statements (2022 and earlier)

Company profile

Business Address 4020 STIRRUP CREEK DRIVE, SUITE 110
DURHAM, NC 27703
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments47,08559,96065,80232,66135,87943,07235,458
Cash and cash equivalents47,08559,96065,80232,66135,87943,07235,458
Prepaid expense1,697406291,2391,818  
Deferred costs    585858
Disposal group, including discontinued operation   114114470977
Other undisclosed current assets5,3481,5142,3477,1646,1381,1551,235
Total current assets:54,13061,51468,77841,17844,00744,75537,728
Noncurrent Assets
Operating lease, right-of-use asset1,6931,3431,3861,444  1,816
Property, plant and equipment12,20110,1898,7033,4932,4061,4106,340
Intangible assets, net (including goodwill)75757575757575
Intangible assets, net (excluding goodwill)75757575757575
Restricted cash and investments583472472472  539
Other noncurrent assets278294302321341330359
Total noncurrent assets:14,83012,37310,9385,8052,8221,8159,129
TOTAL ASSETS:68,96073,88779,71646,98346,82946,57046,857
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6,9648,3407,0632,7943,3151,8752,891
Accounts payable2,1702,9191,8001,0011,1921721,269
Accrued liabilities3,2514,3534,4631,286969920996
Employee-related liabilities1,5431,0688005071,154783626
Deferred revenue2,5862,5862,9902,9902,9904,4014,401
Debt   836478119 
Other undisclosed current liabilities1,6001,7401,5521,9651,9171,6542,199
Total current liabilities:11,15012,66611,6058,5858,7008,0499,491
Noncurrent Liabilities
Long-term debt and lease obligation3,6132,9733,0953,2404788374,782
Long-term debt, excluding current maturities   120478837 
Operating lease, liability3,6132,9733,0953,120  4,782
Liabilities, other than long-term debt10,7366,8927,2408,6599,0254,1845,291
Deferred revenue10,6656,8187,0877,8348,2383,7604,860
Other liabilities7174153825787424431
Other undisclosed noncurrent liabilities25,14225,17125,45025,64925,64926,04727,330
Total noncurrent liabilities:39,49135,03635,78537,54835,15231,06837,403
Total liabilities:50,64147,70247,39046,13343,85239,11746,894
Stockholders' equity
Stockholders' equity attributable to parent18,31926,18532,3268502,9777,453(37)
Common stock22215141412
Treasury stock, value(155)(155)(155)(155)(155)(155)(155)
Additional paid in capital297,441297,074296,731259,219252,395250,236234,343
Accumulated deficit(278,969)(270,736)(264,252)(258,229)(249,277)(242,642)(234,237)
Total stockholders' equity:18,31926,18532,3268502,9777,453(37)
TOTAL LIABILITIES AND EQUITY:68,96073,88779,71646,98346,82946,57046,857

Income statement (P&L) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Revenues6557377478191,0691,3171,321
Gross profit:6557377478191,0691,3171,321
Operating expenses(8,747)(7,220)(7,802)(9,104)(8,581)(9,716)(9,414)
Operating loss:(8,092)(6,483)(7,055)(8,285)(7,512)(8,399)(8,093)
Nonoperating income (expense)(141)(1)1,032(667)877(6)7
Other nonoperating income (expense)(144)(5)73(670)873(8)(3)
Interest and debt expense  956    
Net loss:(8,233)(6,484)(5,067)(8,952)(6,635)(8,405)(8,086)
Other undisclosed net loss attributable to parent  (956)    
Net loss available to common stockholders, diluted:(8,233)(6,484)(6,023)(8,952)(6,635)(8,405)(8,086)

Comprehensive Income ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net loss:(8,233)(6,484)(5,067)(8,952)(6,635)(8,405)(8,086)
Comprehensive loss:(8,233)(6,484)(5,067)(8,952)(6,635)(8,405)(8,086)
Other undisclosed comprehensive loss, net of tax, attributable to parent  (956)    
Comprehensive loss, net of tax, attributable to parent:(8,233)(6,484)(6,023)(8,952)(6,635)(8,405)(8,086)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: